Shorts here have nothing relevant to say ,
to do this one need some knowledge on the subject ..and they still posting that Leronlimab never finished any study meeting any endpoint ..
Hello , let’s only talk about HIV combo , when with 350 mg efficacy was 81% .. not one serious side effect .
The other 2 approved at the time drugs ..
—- Ibalizumab with 43% efficacy , and
—- Maraviroc with 45% .
They know nothing . So the only thing they doing on this MB is person attacks , and insults on EVERY long , and on some more then another .
Few shorts here behaving as a real stalkers .. they scary at times .
No , they have nothing smart to say , they know nothing smart , so don't expect it from them ..
All imo .
GLTA longs .
Bullish
Market Data 
Markets 
AI
